Home
Company
History
Management
Board of Directors
How to find us
Strategy
Pipeline
Partnering
PENTRA® Technology
PENTRA® Antibody Fragments
Background
Intellectual Property
Glossary
Investors
Media
News
Presentations
Publications
Conferences
Contact
|
Career
|
Disclaimer
|
Print
select
German
French
Italian
Board of Directors
Dr. Thomas Hecht
Chairman
Dr. Chandra P. Leo
Vice Chairman, HBM Partners
Dr. Hamish Cameron
SV Life Sciences
Dr. Thomas Dyrberg
Novo A/S
Dr. Dominik Escher
ESBATech, an Alcon Biomedical Research Unit
Dr. Arnd Kaltofen
VI Partners
Dr. Gerhard Ries
BioMedinvest
© 2012
Delenex Therapeutics AG | Wagistrasse 27 | CH-8952 Schlieren/Zürich | Switzerland